A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids-Reference-Cited by-同舟云学术

A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids

Published:2017-06 Issue:11 Volume:25 Page:2901-2916
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Zhu Mingzhao,Harshbarger Wayne D.,Robles Omar,Krysiak Joanna,Hull Kenneth G.,Cho Sung Wook,Richardson Robyn D.,Yang Yanyan,Garcia Andres,Spiegelman Lindsey,Ramirez Bianca,Wilson Christopher T.,Yau Ju Anne,Moore James T.,Walker Caitlen B.,Sacchettini James C.,Liu Wenshe R.,Sieber Stephan A.,Smith Jeffrey W.,Romo Daniel

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference84 articles.

1. Multitargeted drugs: the end of the ‘one-target-one-disease’ philosophy?

2. Polypharmacology in Drug Discovery;Peters,2012

3. Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

4. Polypharmacology: drug discovery for the future

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification analysis of fatty acid synthase inhibitors using multialgorithms on topological descriptors and structural fingerprints;Chemical Biology & Drug Design;2022-09-15

2. Covalent Inhibition of the Human 20S Proteasome with Homobelactosin C Inquired by QM/MM Studies;Pharmaceuticals;2022-04-25

3. Exploring EZH2-Proteasome Dual-Targeting Drug Discovery through a Computational Strategy to Fight Multiple Myeloma;Molecules;2021-09-14

4. β-Lactone Derivatives and Their Anticancer Activities: A Short Review;Current Topics in Medicinal Chemistry;2021-07

5. Synthesis and Antiproliferative and Antilipolytic Activities of a Series of 1,3- and 1,4-Bis[5-(R-sulfanyl)-1,2,4-triazol-3-yl)benzenes;Russian Journal of Organic Chemistry;2021-07